Nasdaq, Inc. (Nasdaq:NDAQ) today announced that Nidec Corporation (OTC:NJDCY) (TYO:6594) and Clinuvel Pharmaceuticals Ltd. (OTC:CLVLY) (ASX:CUV) have joined the Nasdaq International Designation program. Through their membership, Nidec and Clinuvel will have access to Nasdaq’s investor relations services and unparalleled visibility assets to increase awareness with investors for their U.S.-traded Level 1 ADRs.
read more...↧